J. Quint

First name
J.
Middle name
K.
Last name
Quint
Stone, P. W., Osen, M., Ellis, A., Coaker, R., & Quint, J. K. (2023). Prevalence of Chronic Obstructive Pulmonary Disease in England from 2000 to 2019. Int J Chron Obstruct Pulmon Dis, 18, 1565-1574. http://doi.org/10.2147/copd.s411739
Requena, G., Czira, A., Banks, V., Wood, R., Tritton, T., Castillo, C. M., et al. (2023). Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 1431-1444. http://doi.org/10.2147/copd.s411437
Morgan, A., Gupta, R. S., George, P. M., & Quint, J. K. (2023). Validation of the recording of idiopathic pulmonary fibrosis in routinely collected electronic healthcare records in England. Bmc Pulm Med, 23, 256. http://doi.org/10.1186/s12890-023-02550-0
Kallis, C., Maslova, E., Morgan, A. D., Sinha, I., Roberts, G., van der Valk, R. J. P., et al. (2023). Recent trends in asthma diagnosis, preschool wheeze diagnosis and asthma exacerbations in English children and adolescents: a SABINA Jr study. Thorax. http://doi.org/10.1136/thorax-2022-219757
Raslan, A. S., Quint, J. K., & Cook, S. (2023). All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD). Int J Chron Obstruct Pulmon Dis, 18, 1207-1218. http://doi.org/10.2147/copd.s407085
Whittaker, H., Rothnie, K. J., & Quint, J. K. (2023). Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England. Thorax. http://doi.org/10.1136/thorax-2022-219320
Czira, A., Requena, G., Banks, V., Wood, R., Tritton, T., Castillo, C. M., et al. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 18, 643-659. http://doi.org/10.2147/copd.s405498
Morgan, A., Maslova, E., Kallis, C., Sinha, I., Roberts, G., Tran, T. N., et al. (2023). Short-acting β(2)-agonists and exacerbations in children with asthma in England: SABINA Junior. Erj Open Res, 9. http://doi.org/10.1183/23120541.00571-2022
Cook, S., Schmedt, N., Broughton, J., Kalra, P. A., Tomlinson, L. A., & Quint, J. K. (2023). Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink. Bmj Open, 13, e065927. http://doi.org/10.1136/bmjopen-2022-065927
Attar-Zadeh, D., Capstick, T., Leese, D., Arnetorp, S., Rapsomaniki, E., Da Costa, K. P., et al. (2023). Healthcare costs associated with short-acting β(2)-agonists in asthma: observational UK SABINA study. Bjgp Open. http://doi.org/10.3399/bjgpo.2023.0015